Instalab

Fumaric Acid

Urine Test
Get an early read on cellular energy and kidney tubule health, beyond what standard urine tests reveal.

Should you take a Fumaric Acid test?

This test is most useful if any of these apply to you.

Watching for Early Kidney Trouble
If you have risk factors for kidney disease, this offers an exploratory signal that may shift before standard kidney numbers move.
Taking Long-Term Medications
If you take fumaric acid esters, tenofovir-based drugs, or other long-term therapies, tracking urinary changes helps catch tubule stress early.
Managing Diabetes or Insulin Resistance
Diabetic kidney injury involves changes in this marker, so tracking it can add an early metabolic dimension to your monitoring.
Running a Full Organic Acid Profile
If you want a deep look at cellular energy and metabolism, this is one piece of a wider panel that reveals how your body burns fuel.

About Fumaric Acid

Your cells run on a chemical cycle that turns the food you eat into usable energy. Fumaric acid (fumarate) is one of the molecules in the middle of that cycle. When you measure it in urine, you get a window into how well that engine is running and how your kidneys are handling its leftovers.

Most people will never have this number checked. But for those tracking deeper metabolic and kidney health, urinary fumarate has surfaced in research as a quiet signal that something upstream may be off, sometimes before standard panels show anything.

What This Marker Actually Reflects

Fumarate is part of the TCA cycle (also called the Krebs cycle), the central chemical loop that produces energy inside the tiny power compartments of your cells (called mitochondria). It sits alongside other cycle intermediates like citrate, succinate, and malate. When your body's energy machinery runs smoothly, fumarate is produced and consumed in roughly balanced amounts.

When fumarate shows up in urine in unusual amounts, it usually means one of three things is happening: the energy cycle inside cells is disrupted, the kidney's filtering and reabsorption is not working as expected, or a rare inherited metabolic problem is at play. The urine test does not tell you which cause is responsible on its own, but it points you in a direction worth investigating.

Kidney Disease and Progression

Some of the current evidence for urinary fumarate ties it to kidney disease progression. In a study of 936 adults with chronic kidney disease, higher baseline urinary fumarate was independently linked to worse kidney outcomes over time, including a 30% drop in kidney filtration, a doubling of creatinine, or progression to end-stage kidney disease. The link held even after adjusting for age, sex, baseline kidney function, protein in the urine, and diabetes.

Fumarate has also been studied as a contributor to diabetic kidney injury, where animal and cell research suggests it may play a role in damage to the filtering cells of the kidney. A separate study found that higher urinary fumarate predicted worse outcomes in a specific autoimmune kidney disease called phospholipase A2 receptor-associated membranous nephropathy.

What this means for you: a rising urinary fumarate trend, especially alongside other signs of kidney stress like protein in the urine or a falling filtration rate, may flag accelerating kidney trouble earlier than waiting for kidney numbers alone to shift.

Inherited Metabolic Disease

Massively elevated urinary fumarate is the hallmark of fumarase deficiency, a rare genetic condition that prevents the body from properly running the energy cycle. People born with it typically show severe brain abnormalities, developmental delay, small head size, and low muscle tone in infancy. Some patients also show elevated levels of certain amino acids in the blood.

This condition is rare and almost always identified in childhood. For adults checking urinary fumarate, fumarase deficiency is not the question being asked, but it is the reason this marker exists in metabolic testing in the first place.

Drug-Induced Kidney Tubule Damage

Fumaric acid esters, prescription drugs used to treat psoriasis and multiple sclerosis, can damage the proximal tubules of the kidney. The result is a condition called Fanconi syndrome, where the kidney leaks substances it normally reabsorbs: glucose, phosphate, amino acids, and small proteins. A similar pattern can appear with tenofovir disoproxil fumarate, an HIV and hepatitis B medication.

The urine changes that accompany this drug-induced kidney injury usually include high levels of small proteins like beta-2-microglobulin (a small protein the kidney normally reabsorbs), glucose in the urine despite normal blood sugar, and phosphate wasting. These often appear before blood creatinine rises. In most cases, stopping or reducing the drug reverses the damage, though some patients develop persistent symptoms or bone problems.

Reconciling What Looks Counterintuitive

Higher urinary fumarate has been linked to worse kidney outcomes in chronic kidney disease, yet in some other settings (like acute brain injury), higher circulating fumarate in blood appears protective. This is not a contradiction. Fumarate is a metabolic intermediate, not a damage signal. Its meaning depends entirely on the context: in a sick kidney, leaked fumarate reflects ongoing tubular and cellular stress, while in a body under acute systemic stress, retained fumarate may reflect a still-functioning energy cycle. Interpret the number in the context of your other labs, not as a universal good or bad.

Why One Reading Is Not Enough

Urinary fumarate is a research and exploratory marker. There are no standardized clinical cutpoints, and labs differ in how they measure and report it. A single result can be shifted by diet, hydration, recent illness, exercise, and time of day. This makes trends far more informative than any one snapshot.

If you choose to track this marker, get a baseline now, retest in 3 to 6 months if you are making meaningful changes (diet, weight, medication, or kidney protection strategy), then at least annually after that. Pair the result each time with your kidney function (eGFR and urine protein) and your blood sugar markers to see whether they are moving together. Trends over time mean far more than any single number.

When Results Can Be Misleading

  • Diet within 24 to 72 hours: organic acid profiles, including TCA cycle intermediates, can shift after meals. A high-carbohydrate or unusual meal the day before testing can change the picture without indicating any real biological problem.
  • Recent intense exercise: strenuous activity changes how your cells burn fuel, which can transiently push TCA cycle intermediates around. Avoid heavy workouts in the 24 hours before collecting urine.
  • Acute illness: infections, fevers, or other short-term stressors can shift cellular metabolism enough to distort a single reading. If you have been sick recently, wait at least a few weeks before testing.
  • Collection errors: urine organic acid tests are sensitive to how the sample is collected, stored, and transported. Follow your lab's instructions exactly. A poorly collected sample can produce numbers that have nothing to do with your biology.

What to Do With an Unexpected Result

If your urinary fumarate is unusually high on a single reading, the first move is to retest after correcting any obvious confounders: avoid intense exercise, eat normally, and time the second sample carefully. If it stays elevated, the next layer is to look at your kidney function. Order or review eGFR, cystatin C, urine albumin-to-creatinine ratio, and a full urinalysis. If you take fumaric acid esters or tenofovir-based medications, ask about checking beta-2-microglobulin or retinol-binding protein in urine, since these can catch early tubule damage.

If the pattern points to kidney involvement, a nephrologist is the right specialist to bring in. If the pattern looks more metabolic, with other TCA cycle intermediates also abnormal, an internist or metabolic specialist can help interpret the full organic acid panel. A single elevated fumarate, on its own with normal kidney and metabolic markers, rarely needs urgent action but is worth tracking over time.

What Moves This Biomarker

Evidence-backed interventions that affect your Fumaric Acid level

Increase
Take fumaric acid ester therapy for psoriasis
Long-term fumaric acid ester therapy can damage the proximal tubules of your kidneys, causing a condition called Fanconi syndrome. The result is urinary leakage of glucose, phosphate, amino acids, and small proteins, which can show up alongside changes in urinary organic acids. Case series of 10 to 11 patients found this damage usually reverses after stopping or reducing the drug, though some develop lasting kidney issues, osteomalacia, or fractures. Risk is higher in women, with longer treatment, and at higher doses.
MedicationModerate Evidence
Increase
Take tenofovir disoproxil fumarate for HIV or hepatitis B
Tenofovir disoproxil fumarate can damage kidney tubules through harm to the cellular power compartments inside tubule cells, producing urinary changes similar to Fanconi syndrome. A study of 48 patients found evidence of this damage detectable in urine, often before blood creatinine changes. If you are on this medication, regular urine monitoring is important to catch tubule injury early.
MedicationModerate Evidence

Frequently Asked Questions

Panels containing Fumaric Acid

Fumaric Acid is included in these pre-built panels.

References

13 studies
  1. Kim Y, Lee J, Kang M, Song J, Kim S, Cho S, Huh H, Lee S, Park S, Jo H, Yang S, Paek J, Park W, Han S, Lee H, Lee JP, Joo K, Lim C, Hwang GS, Kim DKKidney3602023
  2. Allegri G, Fernandes MJ, Scalco F, Correia P, Simoni RE, Llerena J, Oliveira MLJournal of Inherited Metabolic Disease2010
  3. Wan ER, Siew K, Heptinstall L, Walsh SClinical Kidney Journal2021
  4. Menzies S, Ismail N, Abdalla a, Collins P, Kirby B, Holian J, Lally aJournal of the European Academy of Dermatology and Venereology2017
  5. Häring N, Sprenger Mähr H, Mündle M, Strohal R, Lhotta KBritish Journal of Dermatology2011